Loading news...
Amitell Capital Pte Ltd reduced its stake in shares of Tenet Healthcare Corporation (NYSE: THC) by 16.1% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 44,592 shares of the company's stock after selling 8,550 shares during the quarter.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Fox Run Management L.L.C. boosted its holdings in shares of Tenet Healthcare Corporation (NYSE: THC) by 538.6% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 8,634 shares of the company's stock after acquiring an additional 7,282 shares
Citigroup Inc. trimmed its holdings in shares of Tenet Healthcare Corporation (NYSE: THC) by 7.4% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 369,555 shares of the company's stock after selling 29,416 shares during the quarter. Citigroup Inc.
Tenet (THC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Insights into Glenview Capital Management's Fourth Quarter 2025 Moves Larry Robbins (Trades, Portfolio) recently submitted the 13F filing for the fourth quarte
Cibc World Market Inc. decreased its position in shares of Tenet Healthcare Corporation (NYSE: THC) by 9.8% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 23,948 shares of the company's stock after selling 2,598 shares during the quarter. Cibc
Alps Advisors Inc. bought a new position in Tenet Healthcare Corporation (NYSE: THC) during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 2,360 shares of the company's stock, valued at approximately $479,000. Several other hedge funds and other institutional investors also recently bought and
THC tops Q4 estimates with strong EBITDA growth, but 2026 guidance midpoint hints at a potential margin dip despite a higher revenue outlook.
Tenet Healthcare Corporation (NYSE: THC - Get Free Report)'s stock price traded up 11.8% during mid-day trading on Wednesday following a stronger than expected earnings report. The stock traded as high as $216.04 and last traded at $215.90. 897,753 shares traded hands during mid-day trading, a decline of 4% from the average session volume of 933,138
Tenet Healthcare Corporation delivered a strong Q4 2025, beating revenue and EPS estimates, and provided favorable 2026 guidance. THC's Ambulatory Care segment drove growth, with a 13.8% revenue increase and robust EBITDA, despite a slight margin decline. The announced $1.9B transaction with CommonSpirit introduces uncertainty but will reduce net debt and grant full ownership of Conifer.
Tenet Healthcare Corporation (THC) Q4 2025 Earnings Call Transcript
Tenet Healthcare Corporation (NYSE: THC) reported fourth-quarter sales of $5.527 billion, up around 8.9% year over year.
The headline numbers for Tenet (THC) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Tenet Healthcare (THC) came out with quarterly earnings of $4.7 per share, beating the Zacks Consensus Estimate of $4.08 per share. This compares to earnings of $3.44 per share a year ago.
DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (Tenet) (NYSE: THC) today announced its results for the quarter ended December 31, 2025. "2025 extended Tenet's track record of strong revenue growth, disciplined operations, improved margins and robust free cash flow generation," said Saum Sutaria, M.D., Chairman and Chief Executive Officer of Tenet. "We see continued demand for acute care and ambulatory surgical services in our markets and are confident in our ability to execute on our str.
THC heads into Q4 earnings with solid expected revenue and admissions growth, but a sharp drop in hospital patient days could cloud the bottom-line outlook.
THC, UHS and OPCH look poised to beat Q4 estimates as volumes, admissions and revenue trends improve.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
AE Wealth Management LLC lowered its stake in shares of Tenet Healthcare Corporation (NYSE: THC) by 60.6% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,809 shares of the company's stock after selling 4,324 shares during the quarter. AE